September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Rebamipide enhances the barrier function of human conjunctival epithelium
Author Affiliations & Notes
  • Yoshiyuki Satake
    Ophthalmology, Tokyo Dental College, Ichikawa, Chiba, Japan
  • Kazunari Higa
    Ophthalmology, Tokyo Dental College, Ichikawa, Chiba, Japan
  • Murat Dogru
    Ophthalmology, Tokyo Dental College, Ichikawa, Chiba, Japan
  • Takefumi Yamaguchi
    Ophthalmology, Tokyo Dental College, Ichikawa, Chiba, Japan
  • Jun Shimazaki
    Ophthalmology, Tokyo Dental College, Ichikawa, Chiba, Japan
  • Footnotes
    Commercial Relationships   Yoshiyuki Satake, Otsuka Pharmaceutical Co., Ltd (F); Kazunari Higa, Otsuka Pharmaceutical Co., Ltd (F); Murat Dogru, Otsuka Pharmaceutical Co., Ltd (F); Takefumi Yamaguchi, None; Jun Shimazaki, Otsuka Pharmaceutical Co., Ltd (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 3507. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Yoshiyuki Satake, Kazunari Higa, Murat Dogru, Takefumi Yamaguchi, Jun Shimazaki; Rebamipide enhances the barrier function of human conjunctival epithelium. Invest. Ophthalmol. Vis. Sci. 2016;57(12):3507.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We previously reported that Rebamipide (Mucosta® Otsuka Pharmaceutical Co., Ltd, Tokyo) accelerated the stratification of cultivated human conjunctival epithelial sheet due to the increased cell proliferation and enhanced the barrier function of the conjunctival epithelium (2014 ARVO). In this study, we investigated the mechanism of barrier function enhancement.

Methods : Human limbal conjunctival tissues from donor corneas were cultured for two weeks to prepare the stratified conjunctival epithelial sheets. Rebamipide (5μM and 20μM) was added to the culture medium for the last four days of cultivation. Expression of the tight junction protein zonular occludens (ZO) 1, which was enhanced in the immunostaining of the stratified human conjunctival epithelial sheet, was confirmed using RT-PCR and Westen blot analysis.

Results : Gene expression of ZO-1 was upregulated under culture condition harboring Rebamipide 20μM, with enhancement of the barrier function. However, in Western blot analysis, obvious differences in the expression of ZO-1 protein for each culture condition were not observed.

Conclusions : A divergent ZO-1 expression pattern between gene and protein was observed. Expression level of ZO-1 protein in Western blot analysis was similar in each condition. However, in the more stratified cultivated human conjunctival epithelial sheet in presence of 20μM Rebamipide, not only an enhancement of ZO-1 expression in the superficial layers, but also an increase of ZO-1 negative cells in the lower layers were observed. Therefore, we conclude that the amount of ZO-1 protein is increased by rebamipide, which also enhanced the barrier function of the conjunctival epithelium.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×